Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TQB3728
i
Other names:
TQB3728, TQB 3728, TQB-3728
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Sino Biopharm
Drug class:
IAP antagonist
Related drugs:
‹
Debio 1143 (1)
27 (0)
BGB-24714 (0)
Comp 3 (0)
MV1 (0)
SM-164 (0)
Debio 1143 (1)
27 (0)
BGB-24714 (0)
Comp 3 (0)
MV1 (0)
SM-164 (0)
›
Associations
News
Trials
Filter by
Latest
over2years
To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. (clinicaltrials.gov)
P1/2, N=78, Not yet recruiting, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
over 2 years ago
New P1/2 trial • Metastases
|
Andewei (benmelstobart) • TQB3728
Share via
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.